Isavuconazole

Drug Profile

Isavuconazole

Alternative Names: BAL 4815; RO 00 94815

Latest Information Update: 10 Sep 2017

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Basilea Pharmaceutica
  • Developer Astellas Pharma; Basilea Pharmaceutica
  • Class Antifungals; Nitriles; Pyridines; Small molecules; Triazoles
  • Mechanism of Action 14-alpha demethylase inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • No development reported Mycoses

Most Recent Events

  • 26 Oct 2016 Pharmacokinetics data from a preclinical study presented at the IDWeek 2016
  • 14 Sep 2016 Isavuconazole licensed to Asahi Kasei Pharma in Japan
  • 16 Jul 2016 No recent reports of development identified for phase-I development in Mycoses(In volunteers) in China (PO)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top